This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

RiceBran Technologies Yönetim

Yönetim kriter kontrolleri 2/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	5.3yrs
Yönetim Kurulu ortalama görev süresi	6.5yrs

Son yönetim güncellemeleri

Recent updates

CEO

RiceBran Technologies CEO'su yok ya da onlar hakkında elimizde veri yok.

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Eric Tompkins	Executive Chairman	less than a year	Veri yok	0.43% € 5.0k
William Keneally	Interim CFO & Secretary	less than a year	Veri yok	0% € 0
Rani Patel	Chief Science Officer	18yrs	Veri yok	Veri yok
Sherry Rhoads	Vice President of Compliance	5.3yrs	Veri yok	Veri yok
Joseph Gutman	Strategic Consultant & Member of Medical Advisory Board	17.3yrs	Veri yok	Veri yok

5.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: NTQ's management team is seasoned and experienced (5.3 years average tenure).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Eric Tompkins	Executive Chairman	less than a year	Veri yok	0.43% € 5.0k
Joseph Gutman	Strategic Consultant & Member of Medical Advisory Board	17.3yrs	Veri yok	Veri yok
David Chemerow	Independent Director	5.3yrs	US$122.50k	2.32% € 26.5k
Barbara Levine	Member of the Scientific Advisory Board	19.2yrs	Veri yok	Veri yok
Eliot Drell	Chairman of Medical Advisory Board	no data	US$4.26k	Veri yok
Harold Stein	Member of Medical Advisory Board	18.8yrs	Veri yok	Veri yok
Brent Rosenthal	Lead Independent Director	7.6yrs	US$144.25k	2.86% € 32.8k
James Flynn	Independent Director	less than a year	Veri yok	Veri yok
Georgina Russell	Independent Director	less than a year	Veri yok	Veri yok

6.5yrs

Ortalama Görev Süresi

66yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: NTQ's board of directors are considered experienced (6.5 years average tenure).

This company listing is no longer active

RiceBran Technologies Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

RiceBran Technologies Announces Board Appointments

RiceBran Technologies, Annual General Meeting, Oct 16, 2023

RiceBran Technologies, Annual General Meeting, Oct 10, 2023

Ricebran Technologies Announces Board Changes

RiceBran Technologies, Annual General Meeting, Jul 14, 2022

Less than half of directors are independent

Recent updates

RiceBran Technologies Announces Board Appointments

RiceBran Technologies announced delayed 10-Q filing

RiceBran Technologies(OTCPK:RIBT) dropped from S&P TMI Index

Ricebran Technologies Receives Staff Delisting Determination from Nasdaq Due to Non-Compliance with the Minimum $2,500,000 Stockholders’ Equity Requirement for Continued Listing as Set Forth in Nasdaq Listing Rule 5550(b)

Ricebran Technologies Receives Non-Compliance Notice from Nasdaq

RiceBran Technologies, Annual General Meeting, Oct 16, 2023

RiceBran Technologies announced delayed 10-Q filing

RiceBran Technologies, Annual General Meeting, Oct 10, 2023

Stabil Nutrition, LLC acquired Stabilized Rice Bran Business from RiceBran Technologies (NasdaqCM:RIBT) for $1.8 million.

RiceBran Technologies Receives Notice from the Staff of the Nasdaq Regarding Non-Compliance with Nasdaq Minimum Bid Price Requirement

Ricebran Technologies Announces Board Changes

First quarter 2023 earnings released: US$0.31 loss per share (vs US$0.29 loss in 1Q 2022)

Full year 2022 earnings released: US$1.43 loss per share (vs US$1.88 loss in FY 2021)

Third quarter 2022 earnings released: US$0.38 loss per share (vs US$0.47 loss in 3Q 2021)

RiceBran Technologies has completed a Follow-on Equity Offering in the amount of $1.499968 million.

RiceBran Technologies has completed a Follow-on Equity Offering in the amount of $1.5 million.

RiceBran Technologies Regains Compliance with Nasdaq Bid Price Rule

RiceBran Technologies, Annual General Meeting, Jul 14, 2022

Less than half of directors are independent

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Third quarter 2021 earnings released: US$0.047 loss per share (vs US$0.068 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.042 loss per share (vs US$0.099 loss in 2Q 2020)

First quarter 2021 earnings released: EPS US$0.013 (vs US$0.076 loss in 1Q 2020)

CEO

Liderlik Ekibi

Ortalama Görev Süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş